J7517 HCPCS Level II code: Mycophenolate mofetil, oral, 250 mg
CMS terminated J7517: its last date of service was Sep 30, 2026. It stays here for looking up older claims; newer services need a current code.
Official description
J7517Mycophenolate mofetil, oral, 250 mg
Short description: Mycophenolate mofetil oral
HCPCS · United States
Medicare details
The indicators CMS publishes with J7517 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- Type of service
- Medical care; Immunosuppressive drugs
- BETOS category
- Other drugs
- Added
- Jan 1, 2000
- Terminated after
- Sep 30, 2026
Where J7517 sits
- 1J codesDrugs administered other than orally
- 2Terminated J7517Mycophenolate mofetil, oral, 250 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
Is HCPCS code J7517 still valid?
No. CMS terminated J7517; its last date of service was Sep 30, 2026. It is listed for looking up services from before then. Use a current code for newer services.
Does Medicare cover J7517?
CMS lists J7517’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J7517
All J codesJ7511Lymphocyte immune globulin, antithymocyte globulin, rabbit, parenteral, 25 mgJ7512Prednisone, immediate release or delayed release, oral, 1 mgJ7513Daclizumab, parenteral, 25 mgJ7514Mycophenolate mofetil (myhibbin), oral suspension, 100 mgJ7515Cyclosporine, oral, 25 mgJ7516Injection, cyclosporine, 250 mgJ7518Mycophenolic acid, oral, 180 mgJ7519Injection, mycophenolate mofetil, 10 mgJ7520Sirolimus, oral, 1 mgJ7521Tacrolimus, granules, oral suspension, 0.1 mgJ7524Mycophenolate mofetil, oral, 5 mgJ7525Tacrolimus, parenteral, 5 mg